arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

SERA PROGNOSTICS, INC.

SERA
$2.06 ▲ +0.06 (+3.25%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
27 Visible periods
24 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

SERA PROGNOSTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $104.0M
Dividend Yield —
Revenue Growth 76.5% ↗
Op. Margin —
ROIC -13.3% ↘
FCF / Share $-0.13 ↗
Trailing P/E —
Price / Book 1.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$30.00K
↑ +76.5% —
Net Income Profit after all expenses
$-8.40M
↓ -2.6% —
FCF / Share Free cash flow per share
$-0.13
↑ +28.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
19
Financial Health ↓
2
Cash Quality ↓
56

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters